2fik

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2fik" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fik, resolution 1.80&Aring;" /> '''Structure of a micro...)
Line 1: Line 1:
-
[[Image:2fik.gif|left|200px]]<br /><applet load="2fik" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:2fik.gif|left|200px]]<br /><applet load="2fik" size="350" color="white" frame="true" align="right" spinBox="true"
caption="2fik, resolution 1.80&Aring;" />
caption="2fik, resolution 1.80&Aring;" />
'''Structure of a microbial glycosphingolipid bound to mouse CD1d'''<br />
'''Structure of a microbial glycosphingolipid bound to mouse CD1d'''<br />
==Overview==
==Overview==
-
Natural killer T (NKT) cells provide an innate-type immune response upon T, cell receptor interaction with CD1d-presented antigens. We demonstrate, through equilibrium tetramer binding and antigen presentation assays with, Valpha14i-positive NKT cell hybridomas that the Sphingomonas glycolipid, alpha-galacturonosyl ceramide (GalA-GSL) is a NKT cell agonist that is, significantly weaker than alpha-galactosylceramide (alpha-GalCer), the, most potent known NKT agonist. For GalA-GSL, a shorter fatty acyl chain, an absence of the 4-OH on the sphingosine tail and a 6'-COOH group on the, galactose moiety account for its observed antigenic potency. We further, determined the crystal structure of mCD1d in complex with GalA-GSL at, 1.8-A resolution. The overall binding mode of GalA-GSL to mCD1d is similar, to that of the short-chain alpha-GalCer ligand PBS-25, but its sphinganine, chain is more deeply inserted into the F' pocket due to alternate, hydrogen-bonding interactions between the sphinganine 3-OH with Asp-80., Subsequently, a slight lateral shift (&gt;1 A) of the galacturonosyl head, group is noted at the CD1 surface compared with the galactose of, alpha-GalCer. Because the relatively short C(14) fatty acid of GalA-GSL, does not fully occupy the A' pocket, a spacer lipid is found that, stabilizes this pocket. The lipid spacer was identified by GC/MS as a, mixture of saturated and monounsaturated palmitic acid (C(16)). Comparison, of available crystal structures of alpha-anomeric glycosphingolipids now, sheds light on the structural basis of their differential antigenic, potency and has led to the design and synthesis of NKT cell agonists with, enhanced cell-based stimulatory activities compared with alpha-GalCer.
+
Natural killer T (NKT) cells provide an innate-type immune response upon T cell receptor interaction with CD1d-presented antigens. We demonstrate through equilibrium tetramer binding and antigen presentation assays with Valpha14i-positive NKT cell hybridomas that the Sphingomonas glycolipid alpha-galacturonosyl ceramide (GalA-GSL) is a NKT cell agonist that is significantly weaker than alpha-galactosylceramide (alpha-GalCer), the most potent known NKT agonist. For GalA-GSL, a shorter fatty acyl chain, an absence of the 4-OH on the sphingosine tail and a 6'-COOH group on the galactose moiety account for its observed antigenic potency. We further determined the crystal structure of mCD1d in complex with GalA-GSL at 1.8-A resolution. The overall binding mode of GalA-GSL to mCD1d is similar to that of the short-chain alpha-GalCer ligand PBS-25, but its sphinganine chain is more deeply inserted into the F' pocket due to alternate hydrogen-bonding interactions between the sphinganine 3-OH with Asp-80. Subsequently, a slight lateral shift (&gt;1 A) of the galacturonosyl head group is noted at the CD1 surface compared with the galactose of alpha-GalCer. Because the relatively short C(14) fatty acid of GalA-GSL does not fully occupy the A' pocket, a spacer lipid is found that stabilizes this pocket. The lipid spacer was identified by GC/MS as a mixture of saturated and monounsaturated palmitic acid (C(16)). Comparison of available crystal structures of alpha-anomeric glycosphingolipids now sheds light on the structural basis of their differential antigenic potency and has led to the design and synthesis of NKT cell agonists with enhanced cell-based stimulatory activities compared with alpha-GalCer.
==About this Structure==
==About this Structure==
-
2FIK is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with NAG, GSL and PLM as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FIK OCA].
+
2FIK is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=GSL:'>GSL</scene> and <scene name='pdbligand=PLM:'>PLM</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FIK OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Wu, D.]]
[[Category: Wu, D.]]
-
[[Category: Zajonc, D.M.]]
+
[[Category: Zajonc, D M.]]
[[Category: GSL]]
[[Category: GSL]]
[[Category: NAG]]
[[Category: NAG]]
Line 25: Line 25:
[[Category: tcr]]
[[Category: tcr]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 10:34:29 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:21:50 2008''

Revision as of 15:21, 21 February 2008


2fik, resolution 1.80Å

Drag the structure with the mouse to rotate

Structure of a microbial glycosphingolipid bound to mouse CD1d

Overview

Natural killer T (NKT) cells provide an innate-type immune response upon T cell receptor interaction with CD1d-presented antigens. We demonstrate through equilibrium tetramer binding and antigen presentation assays with Valpha14i-positive NKT cell hybridomas that the Sphingomonas glycolipid alpha-galacturonosyl ceramide (GalA-GSL) is a NKT cell agonist that is significantly weaker than alpha-galactosylceramide (alpha-GalCer), the most potent known NKT agonist. For GalA-GSL, a shorter fatty acyl chain, an absence of the 4-OH on the sphingosine tail and a 6'-COOH group on the galactose moiety account for its observed antigenic potency. We further determined the crystal structure of mCD1d in complex with GalA-GSL at 1.8-A resolution. The overall binding mode of GalA-GSL to mCD1d is similar to that of the short-chain alpha-GalCer ligand PBS-25, but its sphinganine chain is more deeply inserted into the F' pocket due to alternate hydrogen-bonding interactions between the sphinganine 3-OH with Asp-80. Subsequently, a slight lateral shift (>1 A) of the galacturonosyl head group is noted at the CD1 surface compared with the galactose of alpha-GalCer. Because the relatively short C(14) fatty acid of GalA-GSL does not fully occupy the A' pocket, a spacer lipid is found that stabilizes this pocket. The lipid spacer was identified by GC/MS as a mixture of saturated and monounsaturated palmitic acid (C(16)). Comparison of available crystal structures of alpha-anomeric glycosphingolipids now sheds light on the structural basis of their differential antigenic potency and has led to the design and synthesis of NKT cell agonists with enhanced cell-based stimulatory activities compared with alpha-GalCer.

About this Structure

2FIK is a Protein complex structure of sequences from Mus musculus with , and as ligands. Full crystallographic information is available from OCA.

Reference

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d., Wu D, Zajonc DM, Fujio M, Sullivan BA, Kinjo Y, Kronenberg M, Wilson IA, Wong CH, Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):3972-7. Epub 2006 Mar 6. PMID:16537470

Page seeded by OCA on Thu Feb 21 17:21:50 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools